Discover 489 paid clinical trials in Providence, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 489
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
for
Ganglioneuroblastoma, Nodular, Neuroblastoma
Location: Providence RI, Boston MA, Hartford CT, New Haven CT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 30
Code: NCT06172296
Phase 3, Recruiting
Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults And Adolescent Participants Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)
for
Central Line Associated Blood Stream Infections (CLABSI)
Location: Providence RI, New York NY, Philadelphia PA,
Sponsor: CorMedix Therapeutics
Sex: All
Age: 12+
Code: NCT06822426
Phase 3, Recruiting
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
Location: Providence RI, Boston MA, Lebanon NH, Mineola NY,
Sponsor: University of British Columbia
Sex: All
Age: 0+
Code: NCT04634240
Recruiting
Project: Every Child for Younger Patients With Cancer
for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: Providence RI, Worcester MA, Boston MA, Springfield MA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 25
Code: NCT02402244
Recruiting
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
for
Metastatic Malignant Neoplasm in the Lung,
Location: Providence RI, Boston MA, Hartford CT, New Haven CT,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT05235165
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
for
Immunoglobulin A Nephropathy (IgAN)
Location: Providence RI, Worcester MA, Boston MA, The Bronx NY,
Sponsor: Biogen
Sex: All
Age: 18+
Code: NCT06935357
Phase 3, Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
for
Acute Myeloid Leukemia
Location: Providence RI, Worcester MA, Boston MA, Hartford CT,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT04293562
Phase 3, Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
for
Acute Leukemia of Ambiguous Lineage,
Location: Providence RI, Worcester MA, Boston MA, Hartford CT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 1
Code: NCT06317662
Phase 2, Recruiting
Strategy for Improving Stroke Treatment Response
for
Ischemic Stroke
Location: Providence RI, Boston MA, Hartford CT, New Haven CT,